Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries

Journal of the American College of Cardiology

Volumn 48, Issue 3, 2006, Pages 446-452

  Hartmann, Marc ^a   von Birgelen, Clemens ^a   Mintz, Gary S ^c   Stoel, Martin G ^b   Eggebrecht, Holger ^b   Wieneke, Heinrich ^b   Fahy, Martin ^c   Neumann, Till ^b   van der Palen, Job ^a   Louwerenburg, Hans W ^a   Verhorst, Patrick M J ^a   Erbel, Raimund ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; TUNICA MEDIA;

EID: 33746208054     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.047     Document Type: Article

References (39)

1. Ariyo A.A., Thach C., Tracy R., and Cardiovascular Health Study Investigators. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 349 (2003) 2108-2115
2. Rhoads G.G., Dahlen G., Berg K., Morton N.E., and Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256 (1986) 2540-2544
3. Rader D.J., Hoeg J.M., and Brewer Jr. H.B. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120 (1994) 1012-1025
4. Wilhelmsen L., Svardsudd K., Korsan-Bengsten K., Larsson B., Welin L., and Tibblin G. Fibrinogen as risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
5. Kannel W.B., Wolf P.A., Castelli W.P., and D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 258 (1987) 1183-1186
6. Ernst E., and Resch K.L. Fibrinogen as a cardiovascular risk factor. a meta-analysis and review of the literature. Ann Intern Med 188 (1993) 956-963
7. Schwartzman R.A., Cox I.D., Poloniecki J., Crook R., Seymour C.A., and Kaski J.C. Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol 31 (1998) 1260-1266
8. Handa K., Kono S., Saku K., et al. Plasma fibrinogen levels as independent indicator of severity of coronary atherosclerosis. Atherosclerosis 77 (1989) 209-213
9. Bolibar I., Kienast J., Thompson S.G., Matthias R., Niessner H., Fechtrup C., and ECAT Angina Pectoris Study Group. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. Am Heart J 125 (1993) 1601-1605
10. Schmermund A., Baumgart D., Görge G., et al. Measuring the effect of risk factors on coronary atherosclerosis. coronary calcium score versus angiographic disease severity. J Am Coll Cardiol 31 (1998) 1267-1273
11. Cantin B., Despres J.P., Lamarche B., et al. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men. (the Quebec Cardiovascular Study). Am J Cardiol 89 (2002) 662-666
12. Shai I., Rimm E.B., Hankinson S.E., et al. Lipoprotein(a) and coronary heart disease among women. beyond a cholesterol carrier?. Eur Heart J 26 (2005) 1633-1639
13. Cremer P., Nagel D., Labrot B., et al. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors. results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 24 (1994) 444-453
14. Bremner W.F., Sothern R.B., Kanabrocki E.L., et al. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J 139 (2000) 164-173
15. Ballantyne C.M. Clinical trials endpoints. angiograms, events and plaque instability. Am J Cardiol 82 (1998) 5-11M
16. von Birgelen C., Hartmann M., Mintz G.S., et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 110 (2004) 1579-1585
17. Terres W., Tatsis E., Pfalzer B., Beil F.U., Beisiegel U., and Hamm C.W. Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 91 (1995) 948-950
18. Uchida T., Inoue T., Kamishirado H., Takayanagi K., and Morooka S. Prediction of short-term progression or regression of atherosclerotic coronary artery disease by lipoprotein(a). a quantitative coronary angiographic study. Angiology 54 (2003) 641-646
19. Matsumoto Y., Daida H., Watanabe Y., et al. High level of lipoprotein(a) is a strong predictor for progression of coronary artery disease. J Atheroscler Thromb 5 (1998) 47-53
20. Tamura A., Watanabe T., Mikuriya Y., and Nasu M. Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction. Br Heart J 74 (1995) 365-369
21. Chironi G., Simon A., Denarie N., et al. Determinants of progression of coronary artery calcifications in asymptomatic men at high cardiovascular risk. Angiology 53 (2002) 667-683
22. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). J Am Coll Cardiol 37 (2001) 1478-1492
23. Schartl M., Bocksch W., Koschyk D.H., et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 104 (2001) 387-392
24. Okkels Jensen L., Thayssen P., Pederson K.E., Stender S., and Haghfelt T. Regression of coronary atherosclerosis by simvastatin. a serial intravascular ultrasound study. Circulation 110 (2004) 265-270
25. von Birgelen C., Hartmann M., Mintz G.S., Baumgart D., Schmermund A., and Erbel R. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (≥12 months) follow-up intravascular ultrasound. Circulation 108 (2003) 2757-2762
26. Tsimikas S., Lau H.K., Han K.R., et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a) short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation 109 (2004) 3164-3170
27. Fink P.C., Römer M., Haeckel R., et al. Measurement of proteins with Behring nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem 27 (1989) 261-276
28. Baumgart D., Haude M., Ge J., et al. Online integration of intravascular ultrasound images into angiographic images. Cath Cardiovasc Diagn 39 (1996) 328-329
29. Jauhiainen M., Koskinen P., Ehnholm C., et al. Lipoprotein(a) and coronary heart disease risk. a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 89 (1991) 59-67
30. Ridker P.M., Hennekens C.H., and Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270 (1993) 2195-2199
31. Liu A.C., and Lawn R.M. Lipoprotein(a) and atherogenesis. Trends Cardiovasc Med 4 (1994) 40-44
32. Maher V.M.G., and Brown B.G. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 6 (1995) 229-235
33. Grainger D.J., Kirschenlohr H.L., Metcalfe J.C., Weissberg P.L., Wade D.P., and Lawn R.M. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260 (1993) 1655-1658
34. Koenig W., and Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 94 (1992) 93-107
35. Hong M.K., Park S.W., Lee C.W., et al. Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina. an intravascular ultrasound study. Clin Cardiol 25 (2002) 225-229
36. Braeckman L., De Bacquer D., Rosseneu M., and De Backer G. Determinants of lipoprotein(a) levels in a middle-aged working population. Eur Heart J 17 (1996) 1808-1813
37. Donders S.H., Lustermans F.A., and van Wersch J.W. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients. Blood Coagul Fibrinolysis 3 (1992) 249-256
38. Romanic A.M., Arleth A.J., Willette R.N., and Ohlstein E.H. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions. Circ Res 83 (1998) 264-269
39. von Birgelen C., de Vrey E.A., Mintz G.S., et al. ECG-gated three-dimensional intravascular ultrasound. feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation 96 (1997) 2944-2952